Balance, diversity and passion are at the core of who we are. Meet the hardworking people who defy convention, shatter glass ceilings, and take companies to the top—all with a unique style and a healthy dose of humor.
A dynamic portfolio
Across healthcare and technology, we partner with companies that improve lives.
Say hello to our extended family. An impressive roster of agile and imaginative companies that are building the future of healthcare and technology, one big idea at a time. Our portfolio of entrepreneurial muscle includes 59 IPOs and 134 M&As. And counting.
A hand in every stage
From the first handshake to the final round, we do what it takes to bring your vision to life.
Canaan is an early-stage venture capital firm that invests in visionaries with transformative ideas. While we love speedy success, we’re acutely aware that greatness comes in many forms and at different times. That’s why we’re not afraid to break the mold to bring something spectacular to life.
A fine balance
The passion you want at your side, plus the experience you want at the table.
Grey Wolf Therapeutics is working on a fresh approach to immuno-oncology that does not directly target the immune system, but instead alters tumor cells by illuminating and priming them for immune system annihilation.
Money laundering – and regulator fines – are expensive pain points for the financial industry. Legacy monitoring systems just haven't cut it, missing 60% of bad activity. Enter the Beam Team, offering API-based and cost-effective monitoring systems that detect and flag suspicious activity fast.
Dozens of industries have been re-thought with the experience-driven, millennial customer in mind. The next business that's ripe for transformation? Party supplies and decor. Enter Coterie, a brand thats's reimagining the party goods experience.
A new generation of entrepreneur is building consumer products and services - ideas that seem crazy today, and will feel intuitive in a few years. So, we’re building out a new generation of investors to attack these opportunities and deepen our consumer practice.
Antiva is working on a first-in-class treatment that, if successful, could make surgery for precancerous cervical lesions caused by the human papillomavirus unnecessary. But when it comes to making that case to investors and doctors — particularly the men who dominate those professions — it has often been an uphill battle.
We’re excited to be launching Canaan Beta, Canaan’s new $20 million seed program that aims to invest in the next wave of consumer technologies across social, eCommerce, gaming and even sectors that haven’t yet been imagined.
We at Canaan are “all in” on the notion that diversity of knowledge and experience breeds the best results. With this as our core value, PACT Pharma immediately captured our imagination and investment.
How far have loyalty programs come in actually cultivating true loyalty from consumers, as opposed to just transactions? Introducing our newest investment in Bumped, which offers the most valuable loyalty tool of all – ownership.
General Partner Wende Hutton is an industry pioneer. Partner Julie Grant chatted with Wende about today’s scientific renaissance, the importance of a team approach and the difference between active and activist investor.